A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE ) (TRAVERSE)

Investigator: David Mobley, MD

Study Coordinator: Brittany Foerster

Status: Enrolling

ClinicalTrials.gov Number: NCT03518034

Phone: 281.276.3053

Protocol Number: Pro00019382


This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.
More to Explore
Live Chat Available